| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Journal of Korean Neurosurgical Society > Volume 25(3); 1996 > Article
Journal of Korean Neurosurgical Society 1996;25(3): 540-543.
BCNU-CDDP Continuous Infusion Chemotherapy in Recurrent Oligodendroglioma.
Sang Min Youn, Chang Hun Rhee, Seung Hoon Lee, Jae Wook Song, Jong Hyun Kim
Department of Neurosugery, Korea Cancer Center Hospital, Sam-Sung Medical Center, Seoul, Korea.
ABSTRACT
Eight patients with recurrent oligodendroglioma were treated with 1.3-bis(2-chloroethyl) nitrosourea(BCNU) and CDD continuous infusion chemotherapy. They were 5 with benign oligodendrogliomas and 3 with anaplastic oligodendrogliomas. All the recurrent tumors had been treated with surgery and radiotherapy. Four patients had already received chemotherapy with ACNU. Seven of them showed response to continuous infusion chemotherapy. The time from the response to progression was 15 to 67 weeks. No severe complication of the chemotherapy was found. In conclusion, BCNU-CDDP continuous infusion chemotherapy is an effective treatment modality in recurrent oligodendrogliomas.
Key Words: Oligodendroglioma; Chemotherapy; BCNU; CDDP
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
CrossRef TDM  CrossRef TDM
  E-Mail
Share:      
METRICS
963
View
1
Download
Related articles
The Prognostic Factors in the Oligodendrogliomas.  1993 September;22(9)
Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma  2015 November;58(5)
Editorial Office
1F, 18, Heolleung-ro 569-gil, Gangnam-gu, Seoul, Republic of Korea
TEL: +82-2-525-7552   FAX: +82-2-525-7554   E-mail: kns61@neurosurgery.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Neurosurgical Society.                 Developed in M2PI
Close layer
prev next